LEADER 01483nam  2200373   450 
001 9910688157403321
005 20230704150721.0
024 7 $a10.5772/intechopen.91075
035   $a(CKB)5850000000050224
035   $a(NjHacI)995850000000050224
035   $a(EXLCZ)995850000000050224
100   $a20230704d2022      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aHigh-throughput screening for drug discovery /$fedited by Shailendra K. Saxena
210  1$aLondon, England :$cIntechOpen,$d2022.
215   $a1 online resource (128 pages)
311   $a1-83962-949-5 
330   $aThe book focuses on various aspects and properties of high-throughput screening (HTS), which is of great importance in the development of novel drugs to treat communicable and non-communicable diseases. Chapters in this volume discuss HTS methodologies, resources, and technologies and highlight the significance of HTS in personalized and precision medicine.
606   $aHigh throughput screening (Drug development)
606   $aDrug Design
615  0$aHigh throughput screening (Drug development)
615  0$aDrug Design.
676   $a615.19
702   $aSaxena$b Shailendra K.$f1950-
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688157403321
996   $aHigh-Throughput Screening for Drug Discovery$92902636
997   $aUNINA